Skip to main content

Articles

FDA Approvals, Payers' Guide
Empliciti (Elotuzumab): First SLAMF7 Antibody Therapy Approved for the Treatment of Patients with Previously Treated Multiple Myeloma
Read More
Clinical Pathways and the Oncology Medical Home: First Steps to Value-Based Patient Care
Read More
Value-Based Purchasing: Implications for Hematology
Read More
Redesigning the Payment Model for Acute Leukemia: Benefits and Challenges of the Episode-of-Care Model
Read More
Measuring Value in Healthcare to Improve Quality
Read More
Multiple Myeloma, Oncology
Multiple Myeloma Therapy in 2015: “An Extraordinary Moment in Oncology”
Read More
Multiple Myeloma, Oncology
All-Oral Regimen May Become a New Standard of Care in Advanced Multiple Myeloma
Read More
Multiple Myeloma, Oncology
Consistent Benefit Over Time in Elotuzumab Studies
Read More
Multiple Myeloma, Oncology
Daratumumab Improves Overall Survival in Multiple Myeloma
Read More
Checkpoint Inhibitors in Lymphoma: A New Universe
Read More
Page 117 of 244
Results 1161 - 1170 of 2436